| 000 | 01430 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515235125.0 | ||
| 264 | 0 | _c20110523 | |
| 008 | 201105s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Jian-ming | |
| 245 | 0 | 0 |
_a[Difference of colon cancer and rectal cancer-from the view of an oncological physician]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cMay 2010 |
||
| 300 |
_a321-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aChromosomal Instability |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMicrosatellite Instability |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aOxaloacetates |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 32 _gno. 5 _gp. 321-3 |
|
| 999 |
_c20059190 _d20059190 |
||